May 22, 2019 - The Zacks Analyst Blog Highlights: Disney, Coca-Cola, Gilead, CME and Entergy
May 21, 2019 - Top Stock Reports for Disney, Coca-Cola & Gilead
May 17, 2019 - Top Gainers: GILD +3.1%. NOG +3.2%. NBRV +2.7%. GOL +2.3%. NIO +1%.Top Losers: LTM -4.7%. SIGA -1.9%. NKTR -1.8%. NVO -1.7%. ZYNE -1.7%.
May 15, 2019 - Mallinckrodt (MNK) concludes enrollment in the phase III study on terlipressin, currently under development for treating adult patients with Hepatorenal Syndrome Type 1.
May 15, 2019 - Key highlights of the past week are regulatory and pipeline updates by the leading biotech companies.
May 13, 2019 - GILD vs. ILMN: Which Stock Is the Better Value Option?
May 10, 2019 - Agenus' (AGEN) earnings beat estimates in the first quarter of 2019. Sales marginally miss the same.
May 09, 2019 - Horizon Therapeutics' (HZNP) sales beat estimates in the first quarter of 2019, primarily owing to strong performance of Krystexxa, Ravicti, Procysbi and Rayos.
May 09, 2019 - Intercept's (ICPT) Q1 revenues top estimates on strong Ocaliva sales, driven by sales force expansion.
May 05, 2019 - Gilead's new CEO, Dan O'Day, gives several hints about where the big biotech is headed in his comments in the Q1 earnings conference call.